Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV.
Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV.
复制标题
DOI：
10.1371/journal.pone.0282539
复制
发表时间：
2023
期刊：
影响因子：
3.7
通讯作者：
中科院分区：
文献类型：
--
作者：
Hepatocellular carcinoma (HCC) is an increasing cause of mortality in Nigeria among persons with HIV (PLH), as access to antiretroviral therapy (ART) improves. In this study we describe clinical, radiological, and laboratory characteristics in Nigerian adults with HCC, with and without HIV, and examine how HIV impacts survival. This prospective observational study was conducted between August 2018 and November 2021 at two Nigerian hospitals [Jos University Teaching Hospital (JUTH) and Lagos University Teaching Hospital (LUTH)]. Subjects ≥18 years with HCC diagnosed according to American Association for the Study of Liver Diseases (AASLD) criteria were included. Baseline characteristics were compared, and Kaplan-Meier curves were generated to estimate survival. 213 subjects [177 (83%) without HIV and 36 (17%) with HIV (PLH)] were enrolled. Median age was 52 years (IQR 42,60) and most subjects were male (71%). 83% PLH were on antiretroviral therapy (ART). Hepatitis B surface antigen (HBsAg) positivity was similar between the two groups [91/177 (51%) without HIV vs. 18/36 (50%) with HIV; p = 0.86]. 46/213 (22%) subjects had active hepatitis C (anti-HCV+/HCV RNA>10 IU/mL). Cirrhosis was more common in PLH but there were no other significant differences in clinical and tumor characteristics between the groups. Overall, 99% subjects were symptomatic and 78% in late-stage HCC. Median overall survival was significantly shorter in PLH vs. without HIV (0.98 months vs 3.02 months, HR = 1.55, 95%CI 1.02, 2.37, p = 0.04). This association was not significant after adjusting for known risk factors including gender, current alcohol use, alpha-fetoprotein (AFP), albumin, and total bilirubin (HR = 1.38, 95%CI 0.84, 2.29, p = 0.21). HCC presented late with an extremely poor overall prognosis, highlighting the urgent need for more intensive surveillance in Nigeria to diagnose HCC at earlier stages. Early diagnosis and management of viral hepatitis, and access to HCC therapies, could prevent early mortality among persons with HCC, especially among PLH.
登录
查看更多内容
美国肝细胞癌的流行病学：我们在哪里？我们去哪里？
影响因子：
13.5
作者：
El-Serag, Hashem B.;Kanwal, Fasiha
通讯作者：
Kanwal, Fasiha
影响因子：
3.8
作者：
Merchante, Nicolas;Rodriguez-Fernandez, Miguel;Pineda, Juan A.
通讯作者：
Pineda, Juan A.
影响因子：
5.8
作者：
Di Benedetto, Fabrizio;Tarantino, Giuseppe;Guaraldi, Giovanni
通讯作者：
Guaraldi, Giovanni
DOI：
10.11604/pamj.2020.36.352.23978
发表时间：
2020
期刊：
The Pan African medical journal
影响因子：
--
作者：
Adesegun OA;Olaniran OH;Bamidele E;Inyang JN;Adegbe M;Binuyo TO;Ehioghae O;Adeyemi O;Oyebisi O;Idowu AO;Ajose O
通讯作者：
Ajose O
影响因子：
3.8
作者：
Dakurah OB;Tamandjou CRT;Zunza M;Preiser W;Maponga TG
通讯作者：
Maponga TG